Tubal and ovarian pathways to pelvic epithelial cancer: A pathological perspective

Histopathology

Volumn 54, Issue 4, 2009, Pages 494-495

  Piek, Jurgen M J ^a   Verheijen, René H M ^b   Van Diest, Paul J ^b  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; PROTEIN BCL 2; PROTEIN P53;

EPITHELIUM TUMOR; GENE MUTATION; HUMAN; LETTER; ONCOGENE; OVARY CARCINOMA; PELVIS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE TUBE CARCINOMA;

FALLOPIAN TUBE NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GERM-LINE MUTATION; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PELVIC NEOPLASMS;

EID: 62149102928     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03237.x     Document Type: Letter

References (9)

1. Jarboe EA, Folkins AK, Drapkin R, Ince TA, Agoston ES, Crum CP. Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective. Histopathology 2008 53 127 138.
2. Piek JM, Torrenga B, Hermsen B et al. Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study. Fam. Cancer 2003 2 73 78.
3. Zweemer RP, van Diest PJ, Verheijen RH et al. Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations. Gynecol. Oncol. 2000 76 45 50.
4. Piek JM, van Diest PJ, Zweemer RP et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J. Pathol. 2001 195 451 456.
5. Piek JM, Verheijen RH, Menko FH et al. Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition. Histopathology 2003 43 26 32.
6. Piek JM, van Diest PJ, Zweemer RP, Kenemans P, Verheijen RH. Tubal ligation and risk of ovarian cancer. Lancet 2001 358 844 845.
7. Piek JM, Verheijen RH, Kenemans P, Massuger LF, Bulten H, van Diest PJ. BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis. Gynecol. Oncol. 2003 90 491.
8. Piek JM, van Diest PJ, Verheijen RH. Ovarian carcinogenesis: an alternative hypothesis. Adv. Exp. Med. Biol. 2008 622 79 87.
9. Piek JM, Van Diest PJ, Verheijen RH, Kenemans P. Cell cycle-related proteins p21 and bcl-2: markers of differentiation in the human Fallopian tube. Histopathology 2001 38 481 482.